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o understand the posttranslational conversion of the
cellular prion protein (PrP
 
C
 
) to its pathologic confor-
mation, it is important to deﬁne the intracellular
trafﬁcking pathway of PrP
 
C
 
 within the endomembrane
system. We studied the localization and internalization of
PrP
 
C
 
 in CHO cells using cryoimmunogold electron micro-
scopy. At steady state, PrP
 
C
 
 was enriched in caveolae both
at the TGN and plasma membrane and in interconnecting
chains of endocytic caveolae. Protein A–gold particles
bound speciﬁcally to PrP
 
C
 
 on live cells. These complexes
were delivered via caveolae to the pericentriolar region
T
 
and via nonclassical, caveolae-containing early endocytic
structures to late endosomes/lysosomes, thereby bypassing
the internalization pathway mediated by clathrin-coated
vesicles. Endocytosed PrP
 
C
 
-containing caveolae were not
directed to the ER and Golgi complex. Uptake of caveolae
and degradation of PrP
 
C
 
 was slow and sensitive to ﬁlipin. This
caveolae-dependent endocytic pathway was not observed
for several other glycosylphosphatidyl inositol (GPI)-anchored
proteins. We propose that this nonclassical endocytic
pathway is likely to determine the subcellular location of
PrP
 
C
 
 conversion.
 
Introduction
 
Prion diseases are fatal neurodegenerative disorders. Trans-
mission studies using transgenic and PrP-ablated (
 
Prnp
 
0/0
 
)
mice have shown that disease is caused by the abnormally
folded prion protein (PrP
 
Sc
 
) (Prusiner, 1994). PrP
 
Sc
 
 is
formed from a glycosylphosphatidyl inositol (GPI)–anchored,
protease-sensitive cellular isoform (PrP
 
C
 
) by a posttransla-
tional refolding process (Oesch et al., 1985; Borchelt et al.,
1990; Caughey and Raymond, 1991). During refolding,
regions of the primarily 
 
 
 
-helical PrP
 
C
 
 molecules are converted
to 
 
 
 
-helical structures (Pan et al., 1993, Wille et al., 2002).
After conversion, PrP
 
Sc
 
 accumulates in a late endocytic lyso-
somal compartment of the infected cell (Taraboulos et al.,
1990; McKinley et al., 1991; Arnold et al., 1995). The
mechanism involved in the conversion of PrP
 
C
 
 to PrP
 
Sc
 
 and
the exact subcellular site of PrP
 
Sc
 
 formation have not yet
been determined.
Posttranslational GPI anchoring, disulfide bonding, and
glycosylation of PrP
 
C
 
 in the ER direct PrP
 
C
 
 through the
Golgi complex into the post-Golgi, cholesterol-rich, caveolae-
like domains (CLDs) (Vey et al., 1996). Caveolae, specialized
membrane microdomains that contain members of the caveolin
protein family, are rich in cholesterol and glycosphingolipids
and often appear as flask-shaped invaginations on the
plasma membrane or form more complex interconnected
chains of several caveolae with a single neck connecting the
chains to the outer surface of the cell (Parton, 2003). Caveolae
mediate a number of key physiological processes, such as signal
transduction and transcytosis (Anderson, 1998; Kurzchalia
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Figure 1. At steady state, PrP
C is enriched in lamellae and caveolae both at the plasma membrane and inside the cell. (A–C) PrP
C was 
immunogold labeled on ultrathin cryosections of CHO/30C3 cells (steady-state distribution of PrP
C) using the R1 recombinant antibody Fab 
fragment against PrP
C. Labeling was observed on the ER (A, arrowheads), plasma membrane caveolae-like structures (A, arrows), caveolae-like 
structures that appeared as flask-shaped invaginations on the plasma membrane (p) and interconnecting chains of caveolae-like structures deeper 
into the cytoplasm (B), and microvilli at the leading edge of the cell (C). Clathrin-coated pits (C, thin arrow) did not label. (D and E) Caveolin-1 
was immunogold labeled on ultrathin cryosections of CHO/30C3 cells using anti-caveolin-1–gold labeling. (D) Caveolae-like structures and 
interconnecting chains of caveolae-like structures deeper into the cytoplasm labeled with a caveolin-1 antibody under steady-state conditions. 
(E) Protein A–gold uptake in an SHaPrP
C-expressing cell, after a 10-min pulse. Gold labeling was observed on the plasma membrane and was 
enriched in caveolae (arrowheads). (F) After a 10-min pulse and 50-min chase, gold labeling was observed in small vesicles near the Golgi complex 
and lysosomes. G, Golgi complex; l, lysosomes; m, mitochondria; n, nucleus; p, plasma membrane. Bar, 200 nm (applies to all panels).T
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and Parton, 1999; Brown and Jacobson, 2001; Conner and
Schmid, 2003; Parton, 2003). CLDs, also called lipid rafts
(Simons and Ikonen, 1997), are biochemically defined in
terms of their Triton X-100 detergent insolubility at 4
 
 
 
C.
Caveolae can be considered a special class of raft. However,
because Triton insolubility is also considered the standard
hallmark of cytoskeletal association of membrane proteins
(Scherfeld et al., 1998), one cannot assume that CLDs are
equivalent to purified caveolae.
CLDs appear to be crucial to the PrP
 
C
 
-to-PrP
 
Sc
 
 conver-
sion process (Taraboulos et al., 1995; Vey et al., 1996;
Kaneko et al., 1997; Naslavsky et al., 1997). PrP
 
C
 
 with
modifications in the cytoplasmic tail, which cause it to be re-
directed to clathrin-coated pits, is not converted to PrP
 
Sc
 
(Taraboulos et al., 1995; Kaneko et al., 1997). Significantly,
neurons in culture (Mouillet-Richard et al., 2000), astro-
cytes, and basal ganglion cells contain caveolae, raising the
possibility that PrP
 
C
 
 resides in these structures. In addition,
many different caveolae-containing cell types outside the
 
nervous system that express PrP
 
C
 
 may be required for the
transmission of prion diseases.
Here we report on the trafficking of PrP
 
C
 
 in CHO cells
stably transfected with either Syrian hamster (SHa) or chi-
meric mouse–hamster (MH2M) PrP
 
C
 
 using cryoimmu-
nogold electron microscopy. We found that PrP
 
C
 
 was highly
enriched in the caveolae and caveolae-containing endocytic
structures of these cell lines.
 
Results
 
PrP
 
C
 
 expression levels do not interfere with caveolin-1 
expression in CHO cells
 
Previous studies demonstrating Triton X-100 detergent insol-
ubility of PrP
 
C
 
 in neuroblastoma (N2a) cells have suggested
that PrP
 
C
 
 is concentrated in CLDs (Ying et al., 1992; Goro-
dinsky and Harris, 1995; Harmey et al., 1995; Vey et al., 1996;
Naslavsky et al., 1997). However, these studies are compli-
cated by the dramatically disparate caveolin levels found in dif-T
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Figure 2. PrP
C is internalized into nonclassical endosomes via caveolae, and this internalization is triggered by surrogate ligand protein 
A–gold. (A) Endocytosed protein A–gold is found in caveolae of SHaPrP
C-expressing CHO/30C3 cells. Cells were incubated at 37 C for 
10 min with protein A–gold (5 nm) and chased for 50 min before fixation. Ultrathin cryosections were labeled with anti–caveolin-1 
(10-nm gold). Protein A–gold (5 nm) detecting PrP
C labeling was observed on the plasma membrane (thin arrow) and was enriched in 
caveolae (arrowheads) and caveolin-1–positive (10-nm gold) structures. Clathrin-coated pit (large arrowhead) did not label for either 
PrP
C or caveolin-1. (B) Tubule and vesicular structures (small arrowhead) that contained endocytosed protein A–gold (5 nm) labeled for 
caveolin-1 (10 nm, large arrow). (C) Caveolae (caveolin-1, 10 nm, thick arrows) were present on endocytic structures that were enriched 
for endocytosed protein A–gold (5-nm gold, small gold, thin arrows). Protein A–gold (5 nm) was also present on the plasma membrane 
(arrowhead). Panel D depicts an endocytic structure loaded with endocytosed protein A–gold (5 nm, thin arrows) with fused caveolae 
(thick arrows) labeled for caveolin-1 (10-nm gold) surrounded by caveolae (arrowheads) at the pericentriolar region of the cell that also 
labeled for caveolin-1 (10 nm) and contained endocytosed protein A–gold (5 nm). Compared with C, the endocytic structure shown 
contained caveolae that have less caveolar appearance, as if they were fused with the endosome. (E) Endocytosed protein A–gold (5 nm) 
was present exclusively on the plasma membrane, on plasma membrane–associated caveolae (caveolin-1, 10 nm, arrowheads), and in 
lysosomes (thin arrows show caveolin-1 label, 10-nm gold). The Golgi complex, labeled for caveolin-1 in a nonclustered fashion, did not 
contain endocytosed protein A–gold (5 nm). Clathrin-coated pit (thick arrow), nuclear envelope–ER, and clathrin-coated vesicles (not 
depicted) did not exhibit endocytosed protein A–gold. c, centriole; e, endocytic structure; G, Golgi complex; l, lysosome; m, mitochondria; 
n, nucleus; p, plasma membrane. Bar, 200 nm (applies to all panels).T
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ferent N2a cells (Ying et al., 1992; Gorodinsky and Harris,
1995; Harmey et al., 1995). To determine the expression lev-
els of caveolin in the CHO cells used in our experiments,
we performed Western blotting to measure levels of both
PrP
 
C
 
 and caveolin-1. Immunoblotting revealed that CHO/
30C3 and CHO/MH2M cell lines express SHaPrP
 
C
 
 and
MH2MPrP
 
C
 
, respectively. Neither the parental, nontrans-
fected CHO/K1 line nor the cell line expressing the empty
vector (CHO/EV) showed a PrP
 
C
 
 signal when probed with
the 3F4 mAb specific for SHaPrP
 
C
 
 and MH2MPrP
 
C
 
 (unpub-
lished data). In addition, these cells did not express detectable
amounts of endogenous PrP
 
C
 
 when analyzed with the poly-
clonal antiserum RO73 that recognizes PrP
 
C
 
 (unpublished
data). When probed with a polyclonal 
 
 
 
-caveolin-1 antibody,
all cell lines were found to express equal levels of caveolin-1
(unpublished data). These results indicate that CHO cells ex-
press caveolin and that the overexpression of SHaPrP
 
C
 
 or
MH2MPrP
 
C
 
 did not alter the levels of caveolin. Because the
results described below were indistinguishable for cells express-
ing SHaPrP
 
C
 
 and those expressing MH2MPrP
 
C
 
, only the re-
sults for CHO/30C3 cells expressing SHaPrP
 
C
 
 are presented.
 
PrP
 
c
 
 is present in caveolae
 
To determine whether PrP
 
C
 
 and caveolin-1 reside in caveo-
lae in CHO cells, we analyzed the distribution of these pro-
teins on ultrathin cryosections. Sections of 30C3 cells were
labeled with anti-PrP
 
C
 
 Fab R1. Anti-PrP
 
C
 
 label was present
on the nuclear envelope and ER (Fig. 1 A), Golgi complex
(see Fig. S1 A, available at http://www.jcb.org/cgi/content/
full/jcb.200304140/DC1), non–clathrin-coated tubules/ves-
icles in the TGN around the pericentriolar region (Fig.
S1 B) and plasma membrane (Fig. 1 A and Fig. S1 C), and
in multivesicular late endocytic structures (Fig. S1 F). In-
tense labeling for PrP
 
C
 
 was detected in structures resembling
caveolae (Fig. 1 A and Fig. S1 D) and at the edges of the
leading lamellae and ruffles of the plasma membrane (Fig. 1
C and Fig. S1 C), interconnecting chains of caveolae-type
structures near the plasma membrane (Fig. 1 B and Fig. S1
D), and far from the plasma membrane (Fig. S1 E). Both
the nucleus and mitochondria exhibited very little back-
ground label. No noticeable gold particles were found in
clathrin-coated pits and vesicles at the plasma membrane
(Fig. 1 C; Fig. 2, A and E; and Fig. S1 D) and TGN (Fig. S1
B), suggesting that PrP
 
C
 
 was not transported via clathrin-
coated pits. This pattern of labeling was specific because the
parental CHO/K1 and CHO/EV cells that do not express
PrP
 
C
 
 did not exhibit any PrP
 
C
 
 label (unpublished data). In
addition, identical labeling was generated with R2, D13,
and D18, three other recombinant Fabs raised against other
regions of PrP (unpublished data). Importantly, all the anti-
bodies labeled PrP
 
C
 
 in glutaraldehyde-fixed cells, a treat-
ment that, in contrast to paraformaldehyde alone, does not
allow lateral movement of GPI-anchored proteins in the
lipid bilayer and therefore prevents artificial molecular clus-
tering in membrane domains (Madore et al., 1999).
Immunogold labeling of caveolin-1 was found in cryosec-
tions of all cell lines irrespective of PrP
 
C
 
 expression. In CHO/
30C3 cells, gold particles were found almost exclusively deco-
rating 40–50-nm invaginated structures on the plasma mem-
brane and internal compartments of similar dimensions (Fig.
1 D and Fig. 2, A and C–E). Gold particles for caveolin-1 and
PrP
 
C
 
 were seen on both the luminal and cytosolic sides of the
membrane. This observation is unlikely to indicate the pres-
ence of caveolin-1 and PrP
 
C
 
 on both sides of the membrane,
but results from a previously described phenomenon in which
the antibody and protein A–gold complex traverse the 20-nm
phospholipid membrane bilayer. Based on these data, we con-
clude that PrP
 
C
 
 is enriched in lamellae and caveolae both at
the plasma membrane and inside the cell.
 
Protein A–gold particles bind to cells expressing PrP
 
C
 
In experiments designed to determine whether the intercon-
necting chains of caveolae-type structures that are far re-
moved from the plasma membrane (Fig. S1 E) are of en-
docytic origin, we used gold probes as markers for the
endocytic pathway. We observed, to our surprise, that pro-
tein A affinity coupled to gold particles bound PrP
 
C
 
-express-
ing cells. All cell pellets that were analyzed for EM exhibited
an intense red color (the color of the gold probe), whereas
the control cells remained white (see Fig. S2 E, available at
http://www.jcb.org/cgi/content/full/jcb.200304140/DC1).
To determine whether protein A–gold binds to PrP
 
C
 
 spe-
cifically, we performed a series of biochemical experiments
in which we compared protein A–gold with IgG-coated
gold and with protein A coupled with FITC. Binding of la-
beled conjugates was performed on the different cells in cul-
ture and on purified proteins immobilized on nitrocellu-
lose. Confluent cells were incubated with protein A–gold,
IgG–gold, or protein A coupled to FITC for 1 h. PrP
 
C
 
-
expressing cells bound protein A–gold (Fig. 1 E) but did
not bind to either IgG–gold by electron microscopy or pro-
tein A–FITC by fluorescence microscopy. Neither CHO/
K1 nor CHO/EV cells that do not express SHaPrP
 
C
 
 bound
protein A (Table I).
 
Table I. 
 
Binding studies using different labeling reagents
Cells Protein A–gold
 
a
 
Goat IgG–gold
 
a
 
Protein A–FITC
 
a
 
CHO/30C3
 
   
 
CHO/MH2M
 
   
 
CHO/EV
 
   
 
CHO/K1
 
   
 
SHaPrP
 
C
 
 (brain derived)
 
 
 
ND ND
SHaPrP
 
C
 
 (30C3)
 
 
 
ND ND
BSA
 
 
 
ND ND
 
a
 
 
 
, binding; 
 
 
 
, no binding.T
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To determine whether purified PrP
 
C
 
 binds to protein
A–gold, we transferred 8 
 
 g of SHaPrP
C isolated from hamster
brain or from CHO/30C3 cells to nitrocellulose and mea-
sured the binding of protein A. SHaPrP
C from brain and
CHO/30C3 cells, but not the control BSA, gave a specific
signal (Table I). To demonstrate unambiguously, via an in-
dependent method, that protein A–gold binds specifically to
PrP
c under native conditions in living cells, we preincubated
SHaPrP
C-expressing cells with and without the anti-PrP Fab
cocktail mix (R1, D13, and D18). This was followed by
sheep anti–mouse Fab that covered the anti-PrP antibodies.
Sheep anti–mouse does not bind directly to PrP
C. PrP
C-
expressing cells that were treated with the cocktail and then
incubated in media containing protein A–gold remained white
(unpublished data). Apparently, the anti-PrP mouse anti-
bodies masked the PrP
C epitope on the living CHO cells
and thus prevented protein A–gold particles from binding.
Based on these findings, we conclude that SHaPrP
C bound
protein A–gold in a specific manner and that no other sur-
face proteins in CHO cells bound to protein A–gold. We
have not tested whether any other PrP
C from other species
reacted with protein A–gold.
PrP
C is endocytosed via caveolae
To investigate the intracellular fate of protein A–gold label in
cells expressing PrP
C, we performed a series of uptake experi-
ments. Protein A–gold was added to the cells for 10 min, fol-
lowed by a wash with or without a chase in medium for
50 min, all performed at 37 C, after which the cells were
fixed. We observed that after the 10-min incubation, protein
A–gold was highly concentrated in 50-nm coated pits that were
morphologically indistinguishable from caveolae (Fig. 1 E, ar-
rowheads). After the 10-min incubation and 50-min chase,
many (non–clathrin-coated) tubulo-vesicular structures in the
pericentriolar region were loaded with protein A–gold. In ad-
dition, accumulation of gold label was seen in multivesicular-
type, relatively round structures without tubular extensions
and  200–300 nm in size, features indicative of late endoso-
mal/lysosomal structures (Fig. 1 F). Later in this study, we
found that these structures contained the lysosomal glycopro-
tein LGP120. Mitochondria, ER, and Golgi complex (Fig. 1,
E and F) were devoid of label. These observations suggest that
the PrP
C–protein A–gold complexes had entered the cells via
caveolae before they were transported to lysosomes.
To confirm that endocytosed protein A–gold particles
were indeed present in caveolae, we labeled the cryosections
from the 10-min pulse with anti–caveolin-1 antibodies. All
structures loaded with endocytosed protein A–gold particles
also labeled for caveolin-1 (Fig. 2, A–E, large gold), thus
confirming their caveolar origin. The apparent lack of PrP
C
label on clathrin-coated pits (Fig. 2 A) precludes the possi-
bility of internalization via this pathway. Interestingly, we
occasionally found long tubular profiles loaded with endocy-
tosed protein A–gold that also labeled for caveolin-1 (Fig. 2
B), illustrating that the endocytosed caveolar compartment
has a tubular component.
Because endocytosed protein A–gold particles accumu-
lated in late endosomal/lysosomal structures, we searched for
an endocytic intermediate in the endosomal pathway. We
found vacuolar structures (Fig. 2 C) resembling endosomes
that had accumulated the endocytosed protein A–gold (thin
arrows). Compared with control cells (Fig. S1 E) where one
can observe PrP
C under steady-state conditions in endocytic
structures, these structures appeared more swollen. Interest-
ingly, these swollen endocytic intermediates were also deco-
rated with caveolae and stained positively for caveolin-1.
Even in the pericentriolar region, endocytosed protein
A–gold particles were present in caveolae that label with caveo-
lin-1 (Fig. 2 D). In addition, fusion profiles of caveolae with
endosomes were observed (Fig. 2 D), while the endocytosed
protein A–gold particles were deposited within the lumen of
the endosome (small arrows). To search for resident mole-
cules of these “rosettes” of endocytic caveolae, we tried label-
ing for different markers. Neither EEA1, Rab 4, nor Rab 5
labeled on these structures, and transferrin receptor did not
colocalize. Thus, only the exogenously provided protein
A–gold was detectable within the compartment in the section,
and the presence of small (50 nm) vesicles within these 200–
300-nm structures was used as a criterion to determine their
endocytic origin. To provide further evidence that under
steady state, caveolae-containing endocytic structures exist,
we incubated the cells at 4 C with protein A–gold and
found similar profiles devoid of protein A–gold but positive
for caveolin-1 (later in this study). We conclude that these
endocytic structures are nonclassical.
We next addressed whether caveolin-1 would remain in
these structures during the endocytic process toward late mul-
tivesicular endosomes/lysosomes. To make this determination,
we evaluated whether caveolin-1 and protein A–gold were
present in multivesicular structures characteristic of late endo-
somal/lysosomal structures. Cells were pulsed with protein
A–gold for 10 min, chased for 50 min, and then sectioned and
labeled with anti–caveolin-1. All late endosomal/lysosomal
structures that were loaded with endocytosed protein A–gold
also labeled for caveolin-1 (Fig. 2 E). At least two to three gold
particles per late endosomal/lysosomal structure that labeled
with caveolin-1 (Fig. 2 E, thin arrows) were usually present on
membranes within the multivesicular/membranous lysosomal
compartment, suggesting lysosomal delivery of caveolin. This
phenomenon was also seen before the uptake experiment (un-
published data), suggesting a possible involvement of the en-
dosomal/lysosomal pathway for caveolin degradation.
To evaluate whether protein A–gold remains bound to
PrP
C in the downstream endocytic compartments, we
asked whether the presence of endocytosed protein A–gold
always correlates with the relative intensity and distribution
of PrP
C on ultrathin cryosections using anti-PrP
C–gold
(Fig. 1, A–C, and Fig. S1, C–F). To address this question,
we labeled the ultrathin cryosections similar to those that
were analyzed in Fig. 1 (E and F) (10-min uptake of pro-
tein A–gold and 10-min uptake plus 50-min chase) with
anti-PrP
C mouse antibody D18 and compared the relative
distribution of this label with the endocytosed protein
A–gold. We analyzed 20 random cross sections and quantified
the ratio of the 10-min protein A–gold uptake. The ratio of
small (10-nm) protein A–gold probe to large (15-nm) anti-
PrP
C–gold remained identical at the leading edge and
within caveolae-type endocytic structures (Fig. S2 A). An
identical correlation was also found between a small (5-nm)
protein A–gold probe and a large (15-nm) anti-PrP
C–gold.T
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Figure 3. PIPLC treatment of SHaPrP
C-expressing CHO/30C3 cells inhibited PrP
C-dependent protein A–gold uptake. Cells expressing PrP
C 
were treated with PIPLC for 2 h and incubated with protein A–gold (5 nm; 10-min pulse and 50-min chase during the last hour of enzyme 
digestion) before fixation. Sections were labeled for PrP
C using the R1 Fab. Only a very small fraction of the protein A–gold (small gold, 
arrowhead) was endocytosed. Only a few (arrow) protein A–gold particles, but no PrP
C labeling (10-nm gold), were observed on the plasma 
membrane. However, abundant labeling for PrP
C was seen in the Golgi. e, endocytic structure; G, Golgi complex; l, lysosome; n, nucleus; 
m, mitochondria; p, plasma membrane. Bar, 200 nm.
However, relatively more small (5-nm) gold was present
due to its much higher binding efficiency. When the caveo-
lae and interconnecting caveolae (Fig. S2 B) and late en-
docytic multivesicular profiles (Fig. S2 C) were analyzed,
we again found a strong correlation between endocytosed
PrP
C (small gold) and the immunolabeling with anti-PrP
C
(large gold) on sections. Similar results were seen with the
cells that were incubated for 10 min followed by the 50-
min chase with protein A–gold (unpublished data), al-
though more anti-PrP
C–gold was seen in late endocytic
structures than in control cells (compare Fig. 1 F with Fig.
S2 C). Quantitative analysis revealed that  90% of the ca-
veolae at the plasma membrane that were present after the
10-min incubation with protein A–gold at 37 C were still
present after the 50-min chase.
To evaluate the rate of proteolysis of PrP
C after the 50-min
chase, we performed Western blot analysis to measure the rel-
ative degradation of PrP
C before and after 1 h of protein
A–gold uptake. Remarkably, no degradation was detected (Fig.
S2 D). These data clearly show that PrP
C is internalized into
nonclassical endosomes via caveolae and that this internaliza-
tion is triggered by surrogate ligand protein A–gold. The rate
of internalization is slow ( 10% of all caveolae), and the trig-
gered degradation of PrP
C is undetectable after 1 h “induced”
internalization. Whether the triggered internalization is “clus-
ter induced” could not be determined. A one-to-one relation-
ship between a protein A molecule and a 5-nm gold particle is
estimated, which argues for unclustered triggering. We ob-
served that under steady state, PrP
C is also present in late en-
docytic multivesicular bodies (Fig. S1 F).T
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Figure 4. Caveolae-mediated uptake of PrP
C is cholesterol dependent. (A) PrP
C-dependent protein A–gold internalization in SHaPrP
C-
expressing CHO/30C3 cells was temperature sensitive. Cells were preincubated with protein A–gold (5 nm) at 4 C before fixation. 
Ultrathin cryosections were labeled with an antibody against caveolin-1 (10-nm gold). Abundant protein A–gold was only seen on the 
plasma membrane and on plasma membrane–associated caveolae (thick arrow). Caveolin-1–positive endocytic structures (arrowheads) 
and caveolae-1 intracellular caveolae (arrowheads) did not exhibit any protein A–gold labeling (compare with Fig. 5). (B) Effect of filipin 
treatment on protein A–gold uptake and the fate of caveolae. Cells were treated for 24 h with filipin followed by a 10-min incubation in 
media that also contained protein A–gold (5 nm) and a 50-min chase at 37 C. Sections were labeled with anti–caveolin-1 (15 nm). A 
significant number of protein A–gold (small size) binding on the membrane was seen but no enrichment in caveolae (arrow). The uptake 
of protein A–gold is sharply reduced; endocytic structures contain protein A–gold (small size) at relatively low levels. No evidence of 
caveolae and no label for caveolin-1 (large gold) can be seen on these endocytic structures. Many caveolin-1–positive (large gold) 
vesicles/tubules are present in the pericentriolar region devoid of small protein A–gold. c, centriole; e, endocytic structure; m, mitochondria; 
n, nucleus; p, plasma membrane. Bars, 200 nm.T
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Protein A–gold uptake is PrP
C dependent 
and sensitive to filipin
To determine whether protein A–gold uptake is dependent
on PrP
C expression at the plasma membrane, CHO/30C3
and CHO/MH2M cells were treated with phosphatidylinosi-
tol-specific phospholipase C (PIPLC) at 37 C before incuba-
tion with protein A–gold to cleave GPI-linked PrP
C on the
plasma membrane and endocytic compartments. Cryosec-
tions of these cells immunogold labeled with an  -PrP
C anti-
body showed no immunoreactivity for PrP
C on the plasma
membrane or endosomal/lysosomal structures (Fig. 3). PrP
C
labeling in ER and the Golgi complex (Fig. 3) remained un-
perturbed, confirming that PrP
C had been removed specifi-
cally from the plasma membrane, endosomes, and lysosomes
by PIPLC. Furthermore, binding and uptake of protein A–gold
on living cells was reduced to  0.1% (20 cells counted in
treated and untreated cells; total  1,000 gold particles
counted) after PIPLC treatment (Fig. 3), demonstrating that
binding and uptake were dependent on the presence of PrP
C
on the cell surface. PrP-deficient CHO/K1 and CHO/EV
cells did not bind or endocytose protein A–gold (unpub-
lished data), further emphasizing the specificity of binding by
PrP
C to protein A–gold.
Several studies have indicated that raft-mediated uptake is
sensitive to drugs that interfere in the homeostasis of choles-
terol in the membrane lipid bilayer. We next analyzed
whether treatment with filipin, a cholesterol-lowering agent,
affects protein A–gold uptake and the fate of caveolae. When
cells were treated for 24 h with filipin, followed by a 10-min
incubation in media that also contained protein A–gold and
a 50-min chase at 37 C, we found no significant reduction of
protein A–gold binding on the plasma membrane. However,
the presence of caveolae at the plasma membrane and the up-
take of protein A–gold were sharply reduced (Fig. 4 B).
Quantitative analysis of 20 random cross sections of cells re-
vealed a 70% decrease in caveolae. In addition, endocytosed
protein A–gold was only sparsely observed in endocytic struc-
tures. No evidence of caveolae and no label for caveolin were
seen on these endocytic structures (Fig. 4 B). Caveolin-1
(large gold)–containing vesicles and tubules around the peri-
centriolar region did not contain endocytosed protein A–gold
(small gold). See Fig. 2 D and Fig. 5 A for comparison in
control cells. However, many caveolin-1–positive vesicles/
tubules were identified in the pericentriolar region as in con-
trol cells (Fig. 2 D and Fig. 5 A). These data show that caveo-
lae-mediated uptake of PrP
C is cholesterol dependent.
Caveolae on endocytic structures
To demonstrate unambiguously the association of endocy-
tosed caveolae with endocytic structures, we compared up-
take of protein A–gold binding to PrP
C at 4 C and at 37 C.
If these caveolae-type “endocytic” structures label with pro-
Figure 5. Endocytosed protein A–gold was found in intracellular caveolae of SHaPrP
C-expressing CHO/30C3 cells that did not contain the 
transferrin receptor. Cells were (A) incubated at 37 C for 10 min with 5-nm protein A–gold or (B) incubated at 37 C for 10 min with 5-nm 
protein A–gold and chased for 50 min before fixation. Ultrathin cryosections were labeled with antitransferrin antibodies (10-nm gold). 
(A) Protein A–gold (5 nm) detecting PrP
C labeling enriched in pericentriolar caveolae that did not colocalize with transferrin receptor–positive 
structures (10-nm gold, arrowheads). Panel B shows an identical result after a 50-min chase but with an accumulation of endocytosed protein 
A–gold in late endocytic multivesicular bodies. Transferrin receptor–positive labeling (10-nm gold) is found in endocytic structures that show 
an identical morphological appearance to PrP
C-containing structures. c, centriole; e, endocytic structure; G, Golgi complex; l, lysosomes; 
m, mitrochondria; n, nucleus; p, plasma membrane. Bars, 200 nm (also apply to Fig. 6).T
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tein A–gold at 4 C, it would indicate that the structures
were not endocytic but invaginations from the plasma mem-
brane that are accessible to protein A–gold at 4 C. Cells
were incubated for 10 min at either 4 C or 37 C with pro-
tein A–gold (5 nm), and the subcellular distribution of the
gold was analyzed on cryosections. To analyze the distribu-
tion of caveolae, the sections were immunogold labeled with
antibodies against caveolin-1 (10-nm gold).
We observed that at 4 C, protein A–gold bound to PrP
C
in caveolae on the cell surface (Fig. 4 A, arrow). However,
after analyzing  100 cells, no protein A–gold label was
found in caveolae-associated endosomes that labeled for ca-
veolin-1 (10-nm gold) (Fig. 4 A). In contrast, at 37 C, many
caveolae-associated endocytic structures were loaded with
protein A–gold bound to PrP
C (Fig. 2, C and D). Thus,
structures labeled with protein A–gold, as described above
(Fig. 1 F; Fig. 2, C–E; Fig. 6; and Fig. S2 C), were endocytic
compartments containing internalized PrP
C. These experi-
ments indicate that caveolae-associated endocytic structures
exist and that efficient uptake of PrP
C into the caveolar en-
docytic pathway occurs only at physiological temperature.
Caveolae containing endocytosed PrP
C do not intersect 
with compartments containing the transferrin receptor 
and are delivered to late endosomal/lysosomal 
compartments via nonclassical endosomes
Previous studies have shown that the transferrin receptor is
subject to endocytosis and recycling via clathrin-coated pits,
early-sorting endosomes, and recycling endosomes. This early
endocytic compartment has been well characterized in CHO
cells (D’Souza-Schorey et al., 1998; Ghosh et al., 1998).
To investigate whether PrP
C endocytosed via caveolae in-
tersects with the classical early endocytic recycling pathway,
cells were subject to chase for 10 min or chase and pulse for
10 and 50 min, respectively, at 37 C with protein A–gold,
and ultrathin cryosections were labeled using an antibody
(H68-4) directed against the transferrin receptor. In sections
of the 50-min pulse–treated cells, many tubulo-vesicular
structures labeled with the transferrin receptor and were
found next to the Golgi complex around the pericentriolar
region (Fig. 5 A). Small protein A–gold particles were indic-
ative of PrP
C molecules taken up via caveolae. Remarkably,
in samples that had a high degree of ultrastructural preserva-
tion (Fig. 5 A),  2% of the small and large gold particles
were present within the same vesicular structure. As soon as
the ultrastructural preservation of cryosections was compro-
mised, structures collapsed and could not be evaluated accu-
rately. These results indicate that typical early endosomes do
not intersect significantly with the endocytic pathway of
PrP
C-containing caveolae.
To determine whether endocytosed PrP
C intersects with
the transferrin receptor compartment on its way to late en-
dosomes/lysosomes, we also evaluated the 50-min pulse pe-
riod. In addition to the typical small tubulo-vesicular struc-
tures (Fig. 5 A) and swollen caveolae-type early endosomes,
many larger multivesicular bodies (“late” endosomal/lysoso-
mal profiles) were loaded with small gold particles represent-
ing endocytosed PrP
C, whereas the transferrin receptor (large
gold) localized in nearby and distinct structures (Fig. 5 B).
As expected, ER, Golgi complex, mitochondria, and nucleus
were not labeled, indicating highly specific labeling in these
experiments. To demonstrate that these findings were not
induced by the protein A–gold uptake, we double labeled
control cells with anti-PrP
C and transferrin receptor; no
colocalization was seen for PrP
C and transferrin receptor (see
Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200304140/DC1). Based on these data, we conclude
that PrP
C molecules endocytose via caveolae to larger en-
docytic structures and that this pathway does not intersect
appreciably with the well-characterized, clathrin-mediated
early endocytic recycling pathway of the transferrin receptor.
However, later during endocytosis, downstream of the
early endocytic sorting/recycling pathway where transferrin
resides, these PrP
C-loaded endocytic structures mix with
typical late endocytic multivesicular bodies on their way to
Figure 6. Endocytosed protein A–gold 
accumulated in lysosomes of SHaPrP
C-
expressing CHO/30C3 cells that 
contained the classical marker for 
late endocytic structures. Cells were 
incubated at 37 C for 10 min with 5-nm 
protein A–gold and chased for 50 min 
before fixation. Ultrathin cryosections 
were labeled with anti–LGP-120 
antibodies (15-nm gold). PrP
C labeling 
(protein A–gold, 5 nm) accumulated in 
LGP-120–positive structures. P, plasma 
membrane.T
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lysosomes. To confirm the identity of these late endocytic
structures, cells were labeled using an antibody against the
lysosomal glycoprotein (LGP-120), a specific marker for
these structures. Large gold (15 nm) anti–LGP-120 colocal-
ized with the endocytosed (5 nm) protein A–gold, demon-
strating the late endosomal/lysosomal distribution of en-
docytosed PrP
C (Fig. 6).
PrP
C follows a different route than other 
GPI-anchored proteins
Our data raise the question of whether other GPI-anchored
proteins follow the same route as PrP
C in CHO cells. To ad-
dress this question, we localized other GPI-anchored pro-
teins in CHO cells. First, we used a CHO cell line stably
expressing human GPI-anchored CD59 (Wheeler et al.,
2002). The conditions of cell culture, fixation, and immu-
nolabeling were identical to those described above for PrP
C.
We found a uniform distribution of anti-CD59 on ER,
Golgi complex, TGN (see Fig. S4 A, available at http://
www.jcb.org/cgi/content/full/jcb.200304140/DC1), and
the plasma membrane (Fig. S4, B and C), with a higher la-
beling density on the lamellae of the leading edge (not de-
picted) but without any enrichment in caveolae (Fig. S4 C).
Furthermore, clathrin-coated pits at the plasma membrane
(Fig. S4 B) were occasionally ( 5% of 200 coated struc-
tures) labeled, and enrichment was seen at steady state in late
endocytic multivesicular bodies (Fig. S4 B).
Next, we used the bacterial toxin aerolysin, which is a
monovalent probe for the glycan core of several GPI-anchored
proteins, to track the fate of a collection of GPI-anchored
proteins (Fivaz et al., 2002). Remarkably, this probe does
not bind GPI-anchored PrP
C (van der Goot, G., personal
communication). Ultrathin cryosections of PrP
C-express-
ing CHO cells, as described above (Fig. 1, A–D), were
incubated with biotinylated aerolysin followed by anti-
biotin–gold. Moderate, but specific, labeling was seen on
the plasma membrane, Golgi complex, and late endocytic
multivesicular bodies (see Fig. S5 A, available at http://
www.jcb.org/cgi/content/full/jcb.200304140/DC1), as de-
scribed previously (Fivaz et al., 2002). We found a distinct,
higher labeling intensity on plasma membrane lamellae (Fig.
S5 B) and no detectable label in caveolae. A clathrin- and ca-
veolin-independent pathway for internalization of CD59 or
aerolysin probe could not be determined morphologically.
These data confirm the differential sorting and fate of
endocytosed GPI-anchored proteins described previously
(Fivaz et al. 2002), including a different port of entry of
PrP
C relative to other GPI-anchored proteins of the same
cell type (this study).
Discussion
Caveolae in neurodegenerative disease
The localization of PrP
C in caveolae generates important
questions about the physiological function of PrP
C and
raises the possibility that caveolae are the site of pathological
events that ultimately lead to prion disease. Caveolin-1 has
been found in both serotonergic and noradrenergic neurons
in culture as well as in cultured astrocytes, glial cells (Silva et
al., 1999), and Schwann cells (Mikol et al., 1999). Caveolae
have also been identified in astrocytes and endothelial cells
in the brain and other tissues, such as intestine and muscle
implicated in prion propagation and transmission (unpub-
lished data). Significantly, interest in caveolae localization
also has arisen from studies on trafficking and processing of
amyloid precursor protein in Alzheimer’s disease (Bouillot et
al., 1996) and the colocalization of huntingtin with caveolin
in caveolae in Huntington’s disease (Peters et al., 2002).
Thus, caveolae-type structures and rafts might be important
subcellular structures for the manifestation of several neuro-
degenerative diseases.
PrP
C is internalized via the caveolar 
endosomal pathway
The ability of caveolae to internalize GPI-anchored proteins
has been questioned because the GPI-anchored folate recep-
tor and caveolin were not observed within endocytic struc-
tures under native conditions (Rothberg et al., 1990, 1992;
van Deurs et al., 1993; Mayor et al., 1994). However, regu-
lated internalization of caveolae has been demonstrated by
morphological (Parton, 1994) and in vitro budding experi-
ments (Schnitzer et al., 1996), by the presence of the motor
protein dynamin on caveolae that mediates budding (Oh et
al., 1998), and by activation of serum albumin receptor
gp60, which triggers caveolae-uptake through Gi-dependent
activation of the Src tyrosine kinase (Minshall et al., 2002).
Important in this regard, the GPI anchor of PrP
C is modified
with sialic acid, allowing PrP
C to reside in a different domain
of the bilayer than either the folate receptor or Thy-1 (Rudd
et al., 2001). This modification may account for the distinct
endocytic properties attributed to PrP
C, although the exact
mechanism of internalization remains to be determined. Our
data concur with recently reported (Thomsen et al., 2002)
findings that demonstrated using GFP-tagged caveolin-1 that
caveolae are highly immobile plasma membrane micro-
domains. These authors concluded that caveolae are not in-
volved in constitutive endocytosis but represent a highly sta-
ble plasma membrane compartment anchored by the actin
cytoskeleton. However, our results show a low, but specific,
level of dynamics and a clear presence of endocytic caveolae
around the pericentriolar region and in nonclassical en-
docytic structures. The anchoring of cytoskeleton on caveolae
was addressed using our EM analysis; bundles of actin (as
close as 20 nm from caveolae) that are located parallel to the
plasma membrane could be seen below some, but not all
( 5%, 20 cells counted), caveolae. Specific distribution of
actin was found around a minority of protein A–gold-
containing caveolae (see Fig. S6, available at http://www.jcb.
org/cgi/content/full/jcb.200304140/DC1). Antitubulin never
showed any close association with caveolae at the plasma
membrane (unpublished data).
Our findings explain earlier reports on the redistribution
and clustering of GPI-anchored proteins in caveolae and
lead us to suggest that caveolae are specific organelles for en-
docytosis (Ying et al., 1992; Sargiacomo et al., 1993; Smart
et al., 1995). This hypothesis is supported by several studies.
First, Pelkmans et al. (2001) described the caveolar endocy-
tosis of SV40 into unique, large peripheral organelles,T
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termed caveosomes, containing neither the classical endoso-
mal markers nor ligands of clathrin-coated vesicles. If caveo-
somes, as described by Pelkmans et al. (2001), are defined as
endocytic compartments that receive caveolin-decorated
vesicles from the plasma membrane irrespective of SV40 vi-
rus, then these nonclassical endosomes can be considered ca-
veosomes. Further investigation will clarify whether these
virus-induced caveosomes are similar to the caveolar en-
docytosis into nonclassic endocytic structures that we ob-
served for endocytosed PrP
C. Second, Nichols et al. (2001)
described a similar pathway taken by a GPI-tagged GFP and
also reported the continuous microtubule- and temperature-
dependent cycling of GPI-linked GFP and GPI-linked
CD59 between the cell surface and trans-Golgi that was in-
dependent of clathrin endocytic machinery. Lamaze et al.
(2001) described the internalization of the lipid raft–associ-
ated interleukin 2 receptor in T cells lacking caveolin-1 via a
novel mechanism independent of clathrin and dependent
upon dynamin. We never found PrP
C to be enriched in
clathrin-coated pits in brain (Mironov et al., 2003). To-
gether, these observations support the hypothesis that two
distinct nonclathrin uptake mechanisms exist that are both
detergent resistant and dynamin dependent. One mecha-
nism is clearly caveolar and the other is of noncoated origin.
Each pathway is associated with unique G proteins (Oh and
Schnitzer, 2001).
The active internalization of PrP
C via caveolae raises new
questions in the study of prion biology. For example, does
the reported signaling activity of PrP
C occur at the plasma
membrane or after caveolae-mediated endocytosis (Mouil-
let-Richard et al., 2000)? Similarly, is endocytosis via cave-
olae a necessary step in the conversion of PrP
C into PrP
Sc,
perhaps because of a change in milieu or in the relative
concentration of PrP conformers or other auxiliary mole-
cules involved in prion propagation (Telling et al., 1995)?
Is the role of PrP
Sc in promoting neuronal cell dysfunction
performed during or after endocytosis? Is the caveolin-
knockout mouse resistant to oral prion infection? Future
studies of this internalization pathway may lead to the
identification of inhibitors of the caveolae-mediated en-
docytosis of PrP
C, and such molecules may be useful as re-
agents for the treatment of prion diseases and other neuro-
degenerative disorders.
Materials and methods
Chemicals and reagents
Protein A–gold, 5-nm gold particles coupled to protein A molecules in a
1:1 anticipated ratio, was produced by J. Griffiths from the Utrecht Univer-
sity Medical School Department of Cell Biology.
Cultured cells
Production of CHO cells expressing SHaPrP
C (CHO/30C3) was reported
previously (Blochberger et al., 1997).
Antibodies and purified PrP
C
For all studies described here, data using Fab R1 are shown. Identical re-
sults were obtained with R2, D13, and Fab D18, which recognizes resi-
dues 133–157 (Peretz et al., 1997; Williamson et al., 1998). The mAb
against caveolin-1 was a gift from M. Lisanti (Albert Einstein College, New
York, NY). See supplemental Materials and methods (available at http://
www.jcb.org/cgi/content/full/jcb.200304140/DC1) for more details of
other antibodies and purified PrP
C.
Binding studies
Binding of labeled conjugates was performed on the different cells in cul-
ture and on purified proteins immobilized on nitrocellulose. Confluent
cells were washed with media twice before incubation for 1 h with media
containing protein A–gold (OD 0.3). See supplemental Materials and
methods for more details.
Immunogold labeling of living cells
To study uptake of protein A–gold, the different cell lines were incubated
for 10 min with media containing protein A–gold and then fixed or chased
for an additional 50 min at 37 C before fixation. See supplemental Materi-
als and methods for more details.
Cryoimmunogold electron microscopy
Subcellular localization of antigens using high-resolution cryoimmunogold
electron microscopy was performed as previously described (Peters and
Hunziker, 2001). See supplemental Materials and methods for more details.
Online supplemental material
The supplemental material (Figs. S1–S6 and supplemental Materials
and methods) is available at http://www.jcb.org/cgi/content/full/jcb.
200304140/DC1. A concise description of the data presented in each sup-
plemental figure is introduced upon citation in the text. Further comments
on the data reported can be found in the online legends. Methodological
details (including the Western blotting procedure) that are not necessary
for understanding the logic and structure of the experiments have been rel-
egated to the supplemental Materials and methods.
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